GBM tumor cells can secret RANKL into TME and increase tumor cell motility to surrounding non-malignant cells, such as astrocytes, and further induce these surrounding cells to secrete TGF-β which in turn reprograms GBM cells to the MES-like invasive type [171]. The gene discussed is TNFSF11; the disease is glioblastoma.